Molecular genetics and gene expression in atherosclerosis

Area of Science:

• Molecular Cardiology
• Genetics
• Pharmacogenetics
• Genomics

Background:

• Molecular cardiology is rapidly expanding, revolutionizing cardiovascular disease understanding and treatment.
• Genetic predisposition to atherosclerotic disease involves complex gene-gene and gene-environment interactions.
• Current understanding of genetic factors in atherosclerosis is incomplete, with limited knowledge of protective genes.

Purpose of the Study:

• To outline the importance of molecular cardiology and genetics in clinical practice.
• To review the role of genetics, pharmacogenetics, and gene expression in atherosclerotic disease.
• To highlight the complexity of genetic factors and their influence on disease development and treatment.

Main Methods:

• Review of current literature on molecular cardiology, genetics, and genomics.
• Discussion of monogenic and multigenic forms of atherosclerotic disease predisposition.
• Exploration of gene-environment interactions and their impact on disease progression.

Main Results:

• Multiple genes are implicated in atherosclerotic disease predisposition, with varying degrees of influence.
• Identified genetic risk factors include lipoprotein (a), ACE genotype, and homocysteine levels.
• Genotype-specific treatments (pharmacogenetics) show promise for personalized cardiovascular disease management.

Conclusions:

• A comprehensive understanding of molecular mechanisms is essential for genetics-based cardiovascular disease treatment.
• Personalized medicine approaches, considering genetic makeup, are vital for effective disease management.
• Future research should focus on protective genes and intricate gene interactions to improve atherosclerotic disease outcomes.